- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04855162
Use of Lung Ultrasound in Evaluating Physiological Response to Awake Self Proning
November 11, 2021 updated by: Jie Li, Rush University Medical Center
The primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
Study Overview
Status
Completed
Conditions
Detailed Description
Lung ultrasound (LUS) has recently gained popularity among the imaging methods to perform bedside assessment of critically ill patients to guide clinical management.
LUS is a non-invasive and easy-to-perform procedure that provides precise data on lung aeration, lung recruitment, lung morphology, and lung perfusion.
Studies have shown that LUS is a useful tool in monitoring lung reaeration in intubated patients diagnosed with traditional ARDS undergoing prone positioning; however there are mixed findings in terms of the use of LUS in predicting potential prone positioning response.
A recent study found that the non-intubated COVID-19 patients who responded to prone positioning had more pronounced disturbances of aeration in posterior regions, however, they only investigated patients' response to the first prone positioning and the information for the patients' outcome is lacking.
In our previous study with intubated COVID-19 patients, we found that patients' response to the subsequent prone positioning had higher predictive value than the response to the first prone positioning.
Therefore, the primary objective of this study is to explore the physiological mechanism of awake, self proning among patients with acute hypoxemic respiratory failure induced by COVID-19, using LUS in the first three days and explore the predictive value of LUS in patients' outcome.
Study Type
Observational
Enrollment (Actual)
74
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Jalisco
-
Guadalajara, Jalisco, Mexico, 44280
- Hospital Civil Fray Antonio Alcalde
-
-
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Adult patients with acute hypoxemic respiratory failure due to COVID-19 who are admitted at Rush University Medical Center
Description
Inclusion Criteria:
- Adult subjects 18 years and older,
- Confirmed COVID-19 diagnosis
- Acute hypoxemic respiratory failure (SpO2/FiO2 or PaO2/FiO2 <300)
- Ordered self-prone positioning per medical team
Exclusion Criteria:
- Pregnant
- Palliative care
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SpO2/FiO2 pre prone in day 1
Time Frame: pre prone in day 1
|
Patients' response of oxygenation using SpO2/FiO2
|
pre prone in day 1
|
|
SpO2/FiO2 post prone in day 1
Time Frame: post prone in day 1
|
Patients' response of oxygenation using SpO2/FiO2
|
post prone in day 1
|
|
SpO2/FiO2 pre prone in day 2
Time Frame: Pre prone in day 2
|
Patients' response of oxygenation using SpO2/FiO2
|
Pre prone in day 2
|
|
SpO2/FiO2 post prone in day 2
Time Frame: Post prone in day 2
|
Patients' response of oxygenation using SpO2/FiO2
|
Post prone in day 2
|
|
SpO2/FiO2 pre prone in day 3
Time Frame: Pre prone in day 3
|
Patients' response of oxygenation using SpO2/FiO2
|
Pre prone in day 3
|
|
SpO2/FiO2 post prone in day 3
Time Frame: Post prone in day 3
|
Patients' response of oxygenation using SpO2/FiO2
|
Post prone in day 3
|
|
Lung Ultrasound Score pre prone in day 1
Time Frame: Pre prone in day 1
|
Patients' response of oxygenation using Lung ultrasound score
|
Pre prone in day 1
|
|
Lung Ultrasound Score post prone in day 1
Time Frame: Post prone in day 1
|
Patients' response of oxygenation using Lung ultrasound score
|
Post prone in day 1
|
|
Lung Ultrasound Score pre prone in day 2
Time Frame: Pre prone in day 2
|
Patients' response of oxygenation using Lung ultrasound score
|
Pre prone in day 2
|
|
Lung Ultrasound Score post prone in day 2
Time Frame: Post prone in day 2
|
Patients' response of oxygenation using Lung ultrasound score
|
Post prone in day 2
|
|
Lung Ultrasound Score pre prone in day 3
Time Frame: Pre prone in day 3
|
Patients' response of oxygenation using Lung ultrasound score
|
Pre prone in day 3
|
|
Lung Ultrasound Score post prone in day 3
Time Frame: Post prone in day 3
|
Patients' response of oxygenation using Lung ultrasound score
|
Post prone in day 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jie Li, Rush University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Weiss TT, Cerda F, Scott JB, Kaur R, Sungurlu S, Mirza SH, Alolaiwat AA, Kaur R, Augustynovich AE, Li J. Prone positioning for patients intubated for severe acute respiratory distress syndrome (ARDS) secondary to COVID-19: a retrospective observational cohort study. Br J Anaesth. 2021 Jan;126(1):48-55. doi: 10.1016/j.bja.2020.09.042. Epub 2020 Oct 10.
- Langer T, Brioni M, Guzzardella A, Carlesso E, Cabrini L, Castelli G, Dalla Corte F, De Robertis E, Favarato M, Forastieri A, Forlini C, Girardis M, Grieco DL, Mirabella L, Noseda V, Previtali P, Protti A, Rona R, Tardini F, Tonetti T, Zannoni F, Antonelli M, Foti G, Ranieri M, Pesenti A, Fumagalli R, Grasselli G; PRONA-COVID Group. Prone position in intubated, mechanically ventilated patients with COVID-19: a multi-centric study of more than 1000 patients. Crit Care. 2021 Apr 6;25(1):128. doi: 10.1186/s13054-021-03552-2.
- Wang XT, Ding X, Zhang HM, Chen H, Su LX, Liu DW; Chinese Critical Ultrasound Study Group (CCUSG). Lung ultrasound can be used to predict the potential of prone positioning and assess prognosis in patients with acute respiratory distress syndrome. Crit Care. 2016 Nov 30;20(1):385. doi: 10.1186/s13054-016-1558-0.
- Avdeev SN, Nekludova GV, Trushenko NV, Tsareva NA, Yaroshetskiy AI, Kosanovic D. Lung ultrasound can predict response to the prone position in awake non-intubated patients with COVID-19 associated acute respiratory distress syndrome. Crit Care. 2021 Jan 25;25(1):35. doi: 10.1186/s13054-021-03472-1. No abstract available.
- Ibarra-Estrada M, Gamero-Rodriguez MJ, Garcia-de-Acilu M, Roca O, Sandoval-Plascencia L, Aguirre-Avalos G, Garcia-Salcido R, Aguirre-Diaz SA, Vines DL, Mirza S, Kaur R, Weiss T, Guerin C, Li J. Lung ultrasound response to awake prone positioning predicts the need for intubation in patients with COVID-19 induced acute hypoxemic respiratory failure: an observational study. Crit Care. 2022 Jun 27;26(1):189. doi: 10.1186/s13054-022-04064-3.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 21, 2021
Primary Completion (Actual)
October 7, 2021
Study Completion (Actual)
October 23, 2021
Study Registration Dates
First Submitted
April 13, 2021
First Submitted That Met QC Criteria
April 21, 2021
First Posted (Actual)
April 22, 2021
Study Record Updates
Last Update Posted (Actual)
November 15, 2021
Last Update Submitted That Met QC Criteria
November 11, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 21040601
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted